Vaccine for COVID-19
What’s new in COVID TRIPS waiver negotiations?

Sangeeta Shashikant from the Third World Network looks at the position of different countries, how pharmaceuticals are profiting from the crisis, and the urgent need for the negotiations to be fast tracked and concluded.

Brazil may reach 1 million COVID-19 casualties by October 2021

According to an independent report conducted in Russia, the Latin American country is experiencing a third wave of infection

Explained: How Intellectual Property Rights are blocking vaccine production

What is standing in the way of expanding production and carrying out mass vaccination campaigns across the world?

Lack of political will and IPR rules stand in the way of mass vaccination for COVID-19

A proposal made by India and South Africa in October last year to waive certain Intellectual Property Rights (IPR) of COVID vaccines has gained massive support across the world. Despite its potential to prevent millions of avoidable deaths, the US and its allies continue to block the proposal at the WTO.

One year of COVID-19 in Brazil: from a little flu to a foreseen tragedy

The fight against the pandemic was dominated by political controversies and a lack of commitment to the lives of the population

COVID-19 vaccines: How soon will life become normal?

Dr. Satyajit Rath talks about the progress of different vaccination campaigns and how the vaccines are faring against the different COVID variants.

MST calls for Bolsonaro’s removal in letter to Brazilian people

In the letter, the MST highlights the key struggles for the next period in defense of the life and rights of the Brazilian people. They declare that forcing Bolsonaro out is urgent and necessary.

Peruvian healthcare workers strike for rights

This week’s episode looks at healthcare workers on strike in Peru, the farmers protest in India, and we have a special segment from Brazil on the vaccine

COVID-19 vaccine: Rich countries might gain, poor ones might suffer

As trials for vaccine candidates continue, the question of which countries will gain access to it has become pressing. Low-income countries are likely to suffer in this regard

COVID-19: Study suggests immunity against SARS-CoV-2 could last for six months

The study analyzed the immune memory against the virus in 185 patients who had recovered from COVID-19. These included patients who were asymptomatic and those who exhibited severe clinical symptoms

Good news on vaccines but what about its delivery?

If we plan to vaccinate the entire Indian people, the states need to be involved in a big way, however, the Modi government has so far centralized all aspects of the management of the epidemic, treating it only as an administrative problem.

What do Covid-19 studies tell us?

In this interview with Dr. Satyajit Rath, we talk about the recent studies done on COVID-19 across the globe. We also look at the state of the vaccines under trial and the delivery mechanisms

    × To Subscribe